Olivier Falut Joins EUROAPI as the New Chief Financial Officer
EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support until the month's end.
Welcoming Olivier Falut
Ludwig de Mot, the Chief Executive Officer of EUROAPI, expressed his enthusiasm: "We are thrilled to welcome Olivier, whose extensive background in the industrial sector will be key to driving our FOCUS-27 transformation project. The entire team and Board sincerely thank Evelyne for her dedication to financing our strategic initiatives."
A Wealth of Experience
Olivier Falut brings nearly three decades of experience in management and finance, having held various financial roles in both listed and unlisted companies, including Fareva, Lactalis, and Bel. His background makes him well-equipped to address the financial strategies that will propel EUROAPI forward.
Olivier’s Vision
Speaking about his new role, Olivier stated, "I am eager to join EUROAPI and contribute to the successful implementation of the FOCUS-27 transformative plan. This initiative represents a new economic momentum which will allow us to pursue significant projects aimed at ensuring sustainable organizational growth for the future."
Impressive Professional Journey
Olivier's career began in the realm of financial auditing, primarily with Ernst & Young both in France and the U.S. His professional journey includes pivotal roles such as head of accounting at Bosch France and CFO for Oberthur Technologies. From 2012 to 2017, he led financial control at Lactalis and later held CFO roles at various companies, bringing both expertise and leadership to each enterprise.
Academic Accomplishments
Academically, Olivier is a graduate of ESSEC Business School, holds master’s degrees in business law, and successfully completed the French bar exam, equipping him with a robust educational foundation to support his financial acumen.
EUROAPI’s Commitment to Innovation
EUROAPI is dedicated to reinventing active ingredient solutions, catering to the needs of customers and patients globally. As a leading player in the active pharmaceutical ingredient sector, we boast close to 200 products and are committed to quality with strong research and manufacturing capabilities centered in Europe.
Our team of 3,650 professionals is relentless in their pursuit of health solutions, ensuring access to essential therapies across over 80 countries. We pride ourselves on delivering high-quality API manufacturing, reinforcing our position in a competitive market.
Future Directions
As EUROAPI embraces the future, the successful integration of Olivier Falut into the executive leadership marks a strategic point in our mission. His experienced insight will be vital in enhancing collaborations and driving innovative solutions that can adapt to evolving market needs.
Contact Information and Resources
For media inquiries, please reach out to Laurence Bollack at +33 (0)6 81 86 80 19 or via email. For investor relations, contact Sophie Palliez-Capian at +33 (0)6 87 89 33 51 or Camille Ricotier at +33 (0)6 43 29 93 79.
Frequently Asked Questions
Who is Olivier Falut?
Olivier Falut is the newly appointed Chief Financial Officer of EUROAPI, bringing nearly 30 years of extensive experience in management and finance.
What is the FOCUS-27 transformation project?
FOCUS-27 is EUROAPI’s strategic initiative aimed at driving significant growth and innovation within the company.
What previous companies has Olivier Falut worked for?
Olivier has worked at several major corporations including Fareva, Lactalis, and Bel, holding key financial positions throughout his career.
How will Olivier contribute to EUROAPI?
Olivier will be responsible for leading financial strategies that support EUROAPI’s business objectives and ensure sustainable growth.
What is EUROAPI’s mission?
EUROAPI aims to provide active pharmaceutical ingredient solutions that meet the diverse needs of customers and patients globally while focusing on quality and innovation.
